![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0491.jpg)
BCR signature:
–
SYK
–
PI3K: idelalisib
–
PKC-β: enzastaurin
–
BTK: ibrutinib
–
PKi: dasatinib
–
mTOR: everolimus
BCL6 inhibitors
Proteasome inhibitors
Apoptosis: ABT-199
IMIDS: lenalidomide
Others
New treatment targeted modalities
Target signaling pathways